Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BIOLASE Inc (NASDAQ:BIOL)

0.7821
Delayed Data
As of Feb 09
 -0.0479 / -5.77%
Today’s Change
0.60
Today|||52-Week Range
2.63
-7.01%
Year-to-Date
No recent news for BIOLASE Inc.

Today’s Trading

Previous close0.83
Today’s open0.83
Day’s range0.76 - 0.84
Volume80,126
Average volume (3 months)175,334
Market cap$48.3M
Dividend yield--
Data as of 02/09/2016

Growth & Valuation

Earnings growth (last year)-29.20%
Earnings growth (this year)+42.22%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-16.09%
P/E ratioNM
Price/Sales2.35
Price/Book1.15

Competitors

 Today’s
change
Today’s
% change
MLSSMilestone Scientific...-0.26-16.15%
PDEXPro-Dex Inc+0.10+4.17%
ALGNAlign Technology Inc+0.01+0.02%
SIROSirona Dental System...-0.45-0.43%
Data as of 02/09/2016

Financials

Next reporting dateMarch 2, 2016
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$47.3M
Annual profit (last year)-$18.9M
Net profit margin-39.97%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Harold C. Flynn
Vice President-
Operations
Richard R. Whipp
Corporate headquarters
Irvine, California

Forecasts

Partner Offers